Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease
- PMID: 22697066
- DOI: 10.1177/039463201202500204
Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a multifactorial disorder characterized by the progressive deterioration of neuronal networks. The primary cause and sequence of its progression are only partially understood but abnormalities in folding and accumulation of insoluble proteins such as beta-amyloid and Tau-protein are both associated with the pathogenesis of AD. Mitochondria play a crucial role in cell survival and death, and changes in mitochondrial structure and/or function are related to many human diseases. Increasing evidence suggests that compromised mitochondrial function contributes to the aging process and thus may increase the risk of AD. Dysfunctional mitochondria contribute to reactive oxygen species which can lead to extensive macromolecule oxidative damage and the progression of amyloid pathology. Oxidative stress and amyloid toxicity leave neurons chemically vulnerable. The mitochondrial toxicity induced by beta-amyloid is still not clear but may include numerous mechanisms, such as the increased permeability of mitochondrial membranes, the disruption of calcium homeostasis, the alteration of oxidative phosphorylation with a consequent overproduction of reactive oxygen species. Other mechanisms have been associated with the pathophysiology of AD. Inflammatory changes are observed in AD brain overall, particularly at the amyloid deposits, which are rich in activated microglia. Once stimulated, the microglia release a wide variety of pro-inflammatory mediators including cytokines, complement components and free radicals, all of which potentially contribute to further neuronal dysfunction and eventually death. Clinically, novel approaches to visualize early neuroinflammation in the human brain are needed to improve the monitoring and control of therapeutic strategies that target inflammatory and other pathological mechanisms. Similarly, there is growing interest in developing agents that modulate mitochondrial function.
Similar articles
-
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.Free Radic Biol Med. 2013 Sep;62:90-101. doi: 10.1016/j.freeradbiomed.2012.11.014. Epub 2012 Nov 29. Free Radic Biol Med. 2013. PMID: 23200807 Free PMC article.
-
When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.Ageing Res Rev. 2014 Nov;18:29-40. doi: 10.1016/j.arr.2014.07.004. Epub 2014 Jul 28. Ageing Res Rev. 2014. PMID: 25078115 Review.
-
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.Neurol Res. 2003 Sep;25(6):665-74. doi: 10.1179/016164103101201977. Neurol Res. 2003. PMID: 14503022
-
Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.Cells. 2020 Sep 21;9(9):2135. doi: 10.3390/cells9092135. Cells. 2020. PMID: 32967303 Free PMC article. Review.
-
Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress.Arch Med Res. 2012 Nov;43(8):632-44. doi: 10.1016/j.arcmed.2012.10.016. Epub 2012 Nov 8. Arch Med Res. 2012. PMID: 23142264 Review.
Cited by
-
NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers.J Clin Biochem Nutr. 2013 Mar;52(2):133-8. doi: 10.3164/jcbn.12-118. Epub 2013 Mar 1. J Clin Biochem Nutr. 2013. PMID: 23526113 Free PMC article.
-
The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Mol Neurobiol. 2013 Dec;48(3):556-70. doi: 10.1007/s12035-013-8445-3. Epub 2013 Apr 3. Mol Neurobiol. 2013. PMID: 23546742 Review.
-
Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).Age (Dordr). 2015 Feb;37(1):9747. doi: 10.1007/s11357-015-9747-3. Epub 2015 Feb 8. Age (Dordr). 2015. PMID: 25663420 Free PMC article.
-
Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369. Eur Rev Med Pharmacol Sci. 2022. PMID: 35363371 Free PMC article. Review.
-
Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease.Neurobiol Aging. 2014 Aug;35(8):1956.e1-8. doi: 10.1016/j.neurobiolaging.2014.01.141. Epub 2014 Feb 5. Neurobiol Aging. 2014. PMID: 24650791 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical